Connection

Matteo Bassetti to Enterobacteriaceae Infections

Back to Details
This is a "connection" page, showing publications Matteo Bassetti has written about Enterobacteriaceae Infections.
Matteo Bassetti
Connection Strength
1.308
Enterobacteriaceae Infections
  1. The ideal patient profile for new beta-lactam/beta-lactamase inhibitors. Curr Opin Infect Dis. 2018 12; 31(6):587-593.
    View in: PubMed
    Score: 0.488
  2. How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? Semin Respir Crit Care Med. 2017 06; 38(3):301-310.
    View in: PubMed
    Score: 0.440
  3. Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020 Oct; 50(10):e13319.
    View in: PubMed
    Score: 0.137
  4. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15). J Antimicrob Chemother. 2017 05 01; 72(5):1386-1395.
    View in: PubMed
    Score: 0.109
  5. Should we take into account ESBLs in empirical antibiotic treatment? Intensive Care Med. 2016 12; 42(12):2059-2062.
    View in: PubMed
    Score: 0.105
  6. Ceftolozane/tazobactam: place in therapy. Expert Rev Anti Infect Ther. 2018 04; 16(4):307-320.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.